Jul 6, 2023 | Event, Featured, Health Policy
Register Today The Food and Drug Administration’s Accelerated Approval Pathway has been a lifeline for patients suffering from serious and life-threatening illnesses – like HIV/AIDs, cancer, and sickle cell disease. For more than 30 years, this pathway has expedited...
Read more
Jun 22, 2023 | Access, Advocacy, Featured
Patients across America are rising up and having their voices heard. The two-day We the Patients Fly-In is the perfect platform to directly engage with members of Congress, learn about the latest policy issues, and most importantly connect, support, and share a voice...
Read more
Feb 14, 2023 | FDA, Featured
Patients Rising Now submitted comments to the Food and Drug Administration (FDA) on making naloxone available as an over-the-counter treatment. Naloxone is a treatment which prevents death in the event of an opioid overdose and is currently only available through...
Read more
Feb 13, 2023 | Featured, Letters Supported
Patients Rising Now joined 58 other organizations in a letter sent to the Centers for Medicare and Medicaid (CMS) on reinstating a Federal Rule prohibiting step therapy in Medicare Advantage plans. In 2012, CMS instituted a prohibition on step therapy in Medicare...
Read more
Feb 10, 2023 | Featured, QALY, Uncategorized
Patients Rising Now sent a letter to the Equal Employment Opportunity Commission (EEOC) regarding the release of its draft Strategic Enforcement Plan (SEP). The draft SEP outlined several new policy changes to enhance protections for employees from vulnerable...
Read more
